BioNTech SE ( NASDAQ:BNTX ) shareholders might be concerned after seeing the share price drop 12% in the last quarter...
The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot.
Investors need to pay close attention to BioNTech (BNTX) stock based on the movements in the options market lately.